Prolonged Seizures: Staccato Alprazolam Study

We are investigating whether Staccato Alprazolam is safe and effective for quickly stopping prolonged seizures in individuals aged 12 and older. The study compares its effects to a placebo to assess its benefits.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Alprazolam
Alprazolam is a substance that helps reduce anxiety and relieve panic attacks.
Placebo
Placebo is an inactive substance given to mimic a treatment so researchers can measure effects caused by patients' expectations.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Mnogoprofilna Bolnitsa Za Aktivno Lechenie Puls AD
#40650: Department of Neurology
Blagoevgrad, Bulgaria
Mnogoprofilna Bolnitsa Za Aktivno Lechenie Higiya AD
#40708: Neurology
Pazardzhik, Bulgaria
Military Medical Academy
#40709: Neurology
Pleven, Bulgaria

Sponsor: UCB Biopharma
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.